Filamentous fungi possess unique features which make them attractive as hosts for the production of heterologous gene products. For example, certain fungal species are capable of secreting large quantities of protein in submerged culture. Selected strains of Aspergillus niger can produce greater than 20 g of glucoamylase I ~ I in industrial fermentations [ 11. Some filamentous fungi, including A. niger, have a long history of safe use for the production of enzymes, food products. antibiotics. and biochemicals. Additionally, there is an extensive knowledge base covering low-cost fermentation and large scale recovery of proteins from filamentous fungi. During the past five years, several laboratories have explored the use of filamentous fungi for the expression and secretion of heterologous proteins (for recent reviews, see . Our laboratory has developed techniques to use the filamentous Deuteromycete fungus A. niger var. awamori as a host organism for the expression and secretion of bovine chymosin and Rhizomucor miehei aspartyl protease (RmAP), two milk-clotting enzymes used commercially in cheese manufacturing.
Chymosin is synthesized in the fourth stomach of suckling calves as a zymogen precursor (preproenzyme) with a 16 amino acid signal peptide and a 42 amino acid propeptide which is autocatalytically removed at low pH [8] . Chymosin is the preferred enzyme for cheesemaking, primarily because it preferentially cleaves a specific Phe-Met bond in tc-casein, resulting in a high degree of milk clotting with a very low amount of non-specific Abbreviations used: g l d , glucoamylase gene; pepA, aspergillopepsin A gene; KmAP, Rhizomucor miehei aspartyl protease.
proteolysis which could produce off-flavoured peptides. Availability of this enzyme is subject to fluctuations in the veal market, and consequently, it is both expensive and frequently in short supply. For these reasons expression of bovine chymosin in micro-organisms has been a goal of several biotechnology companies, and to date researchers have expressed bovine chymosin cDNA sequences in bacteria [9, lo] [15] . Three of the plasmid constructions involved coupling of prochymosin cDNA to glaA sequences at either the glucoamylase signal peptide cleavage site (pGKG l), the glucoamylase propeptide cleavage site (pCRG2), or after 11 codons of the mature glucoamylase (pCRG4). A fourth construction involved joining preprochymosin sequences directly to the glaA promoter (pCRG3).
Transformants generated with each of the four expression vectors secreted active chymosin into the culture medium when they were grown in medium which contained starch or maltose as sole carbon sources to induce the glaA promoter ( There was no apparent correlation beween chymosin expression levels and the number of integrated gene copies in the transformants. Hybridization analysis suggested that the steady-state levels of chymosin-specific mRNA were at least as high as glucoamylase mRNA levels in the transformants. Furthermore, hybridization analysis of mRNA purified by oligo-(dT)-cellulose chromatography suggested that virtually all of the chymosin message was poly- RmAP is a microbial chymosin substitute which is frequently used when supplies of chymosin become limited, resulting in high coagulant prices. In addition, microbial milk coagulants such as RmAP are frequently used to manufacture lower grades of cheese. The natural source of RmAP is the Zygomycete fungus R. miehei (formerly Mucor miehei). RmAP shares several characteristics in common with bovine chymosin including a significant degree of primary amino acid sequence similarity, especially in regions surrounding active-site aspartic acid residues. In addition, RmAP is first synthesized as a zymogen which requires activation by proteolytic removal of the propeptide [20] . The gene encoding RmAP was first isolated by Gray etal [21] who expressed it in A. nidulans under control of its own promoter.
Active RmAP was detected in the culture filtrate suggesting that the preproenzyme was secreted and processed to the mature form in A. nidulans. RmAP has also been produced in Aspergillus oryzae using a host a-amylase promoter to control expression [22] . In small-scale fermentations, greater than 3 g of the RmAP I -' was obtained from these A. oryzae transformants. Interestingly, using the equivalent A. oryzae expression system only about 10 mg of bovine chymosin I-' was obtained [23] . We have obtained high level production of RmAP in A. niger was actually produced by the transformants). The reduction in milk-clotting activity caused by hyperglycosylation is very similar to that noted above for glycosylated chymosin and for Rhizomucor pusillus aspartyl protease expressed in yeast [25] . Based on a high degree of conservation in the three-dimensional structures of aspartyl proteases [%I, one of the glycosylation sites in RmAP (Asn") is probably located on the 'flap' region of the protease molecule overhanging the active site cleft. It As these LAB have been used for many generations they are generally regarded as safe (GRAS) organisms and it is argued that the enzymes from these sources will be acceptable to the food industry for biotechnological processes.
There is therefore significant interest in these organisms and their enzymes with the view to their exploitation in new areas of food biotechnology.
Existence of flavour peptides
From other food sources, polar hydrophilic peptides have been reported to have flavour properties. Glutamyl oligopeptides such as Glu-Asp, Glu-Glu, Glu-Ser, and Glu-Gly-Ser, isolated from a proteinase-modified soy bean protein, were the first peptides demonstrated to have favourable taste properties [ 21. Similar acidic oligopeptides were found when fish protein concentrate was hydro-
